← Back to headlines
Moderna Stock Plunges After Cancer Vaccine Breakthrough
Moderna's stock plunged by over 20%, wiping out billions in market value, just one day after a significant breakthrough in its cancer vaccine research had sent shares soaring. The sharp decline followed an initial surge of 177%.
20 Aug, 14:04 — 20 Aug, 17:28
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center2
Center (2)
forbesthestreet
Right
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 2 of 3 sources
forbes8d ago
Moderna Stock Plunges 25%—Wiping Out $18 Billion After Historic Cancer Vaccine Breakthrough
The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before investors pulled back.
By Ty Roush, Forbes Staff
Read full article →thestreet8d ago
135-year-old healthcare giant surges on cancer vaccine breakthrough
A new mRNA cancer vaccine hit its goal in melanoma patients, giving a healthcare giant a fresh growth story.
By Aditya Raghunath
Read full article →Coverage Timeline
First report: thestreet · 20 Aug, 14:04|Full coverage: 3 · 3h|Window: 3h
Left-leaningCenterRight-leaning
